2m 2m 2m 2m 2m 2m 2m
TREVI THERAPEUTI (TRVI)
NASDAQ
$13.92-$0.26 (-1.83%)
Price as of Oct 02, 2026 4:15 PM EDT- $2.0BMarket Cap
- 48.33%1-Year Change
- BiotechnologyIndustry
TREVI THERAPEUTI (TRVI)
$13.92-$0.26 (-1.83%)
TRVI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.18 | ||
Change | -$0.14 (-0.98%) | ||
Open | $14.30 | ||
High | $14.66 | ||
Low | $14.08 | ||
Previous Close | $14.32 | ||
Volume | 3,145,314 | ||
30-Day Average Volume | 1,666,459 | ||
1-Week Change | -3.37% | ||
1-Month Change | -14.42% | ||
1-Year Change | 48.33% | ||
3-Year Change | 550.46% | ||
5-Year Change | 999.22% | ||
Fundamentals | |||
Shares Outstanding | 142.5M | ||
Total Assets | $330.5M | ||
Market Cap | $2.0B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$17.8M | ||
Free Cash Flow | -$17.6M | ||
EBIT | -$17.8M | ||
EBITDA | -$17.8M | ||
Net Working Capital | $317.0M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -111 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -129 | ||
PEG | 6 | ||
Price/Free Cash Flow | -115 | ||
Price/Operating Cash Flow | -116 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue